Home › Steatotic Liver Disease › Pennsylvania
Steatotic Liver Disease clinical trials in Pennsylvania
5 studies for Steatotic Liver Disease are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Philadelphia
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Hershey
- Akero Clinical Study Site, Philadelphia
- Akero Clinical Study Site, Philadelphia
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 12, 2026 · NCT06528314Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Geisinger Medical Center, Danville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 9, 2026 · NCT07631637A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Philadelphia
- 89bio Clinical Study Site, Pittsburgh
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT06419374A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- US Digestive Health - Flourtown, Flourtown
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- US Digestive Health - Wyomissing, Wyomissing
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07165028From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.